Literature DB >> 20963612

[Analgesic therapy of calciphylaxis with levomethadone : a case study].

M Poels1, R Joppich, K Gerbershagen, F Wappler.   

Abstract

Calciphylaxis, or calcific uremic arteriopathy, is a rare complication of end-stage renal impairment. It is characterized by calcification of arterioles and development of intensely painful subcutaneous ischemic ulcerations. While symptomatic management is the mainstay of treatment, particular emphasis is placed on adequate analgesia. Conventional analgesic concepts have mostly proved to be insufficient which increases the extreme suffering of patients. This case report describes the successful analgesic treatment of calciphylaxis with levomethadone.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20963612     DOI: 10.1007/s00482-010-0984-1

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  17 in total

Review 1.  Secondary hyperparathyroidism in chronic renal failure: pathogenic and clinical aspects.

Authors:  F Llach; F Velasquez Forero
Journal:  Am J Kidney Dis       Date:  2001-11       Impact factor: 8.860

2.  A German model for methadone conversion.

Authors:  F Nauck; C Ostgathe; E D Dickerson
Journal:  Am J Hosp Palliat Care       Date:  2001 May-Jun       Impact factor: 2.500

3.  Pharmacokinetics of pregabalin in subjects with various degrees of renal function.

Authors:  Edward J Randinitis; Edward L Posvar; Christine W Alvey; Allen J Sedman; Jack A Cook; Howard N Bockbrader
Journal:  J Clin Pharmacol       Date:  2003-03       Impact factor: 3.126

Review 4.  Calcification and cardiovascular health: new insights into an old phenomenon.

Authors:  Markus Ketteler; Georg Schlieper; Jürgen Floege
Journal:  Hypertension       Date:  2006-04-17       Impact factor: 10.190

Review 5.  Symptomatic management of calciphylaxis: a case series and review of the literature.

Authors:  Mark N Polizzotto; Tamsin Bryan; Michael A Ashby; Peter Martin
Journal:  J Pain Symptom Manage       Date:  2006-08       Impact factor: 3.612

Review 6.  Calcific uraemic arteriolopathy: an update.

Authors:  Natasha M Rogers; Patrick Toby H Coates
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-11       Impact factor: 2.894

Review 7.  Hyperalgesia and opioid switching.

Authors:  Sebastiano Mercadante; Edoardo Arcuri
Journal:  Am J Hosp Palliat Care       Date:  2005 Jul-Aug       Impact factor: 2.500

8.  Effects of varying degrees of renal impairment on the pharmacokinetics of duloxetine: analysis of a single-dose phase I study and pooled steady-state data from phase II/III trials.

Authors:  Evelyn D Lobo; Michael Heathman; Han-Yi Kuan; Shobha Reddy; Lisa O'Brien; Celedon Gonzales; Michael Skinner; Mary Pat Knadler
Journal:  Clin Pharmacokinet       Date:  2010-05       Impact factor: 6.447

Review 9.  Pharmacology of methadone and its isomers.

Authors:  C E Inturrisi
Journal:  Minerva Anestesiol       Date:  2005 Jul-Aug       Impact factor: 3.051

10.  Pain management in chronic kidney disease: the pharmacokinetics and pharmacodynamics of hydromorphone and hydromorphone-3-glucuronide in hemodialysis patients.

Authors:  Sara N Davison; Patrick R Mayo
Journal:  J Opioid Manag       Date:  2008 Nov-Dec
View more
  1 in total

1.  Update on cutaneous calciphylaxis.

Authors:  Uwe Wollina
Journal:  Indian J Dermatol       Date:  2013-03       Impact factor: 1.494

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.